SCHEMBL9354726

SCHEMBL9354726

O=C1CCCN(C(=O)OC(Cc2ccccc2)C(=O)OCc2ccccc2)C1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ TMEM97 Q5BJF2 11/20 0.44
▸ SIGMAR1 Q99720 11/20 0.44
▸ CASP1 P29466 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ CTRB1 P17538 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9354731 1.00 CYP2C19 (0.45) CYP2C19CYP3A4CYP2C9TMEM97SIGMAR1
SCHEMBL9358821 0.93 MEN1 (0.42) CYP2C19CYP3A4CYP2C9TMEM97SIGMAR1
SCHEMBL9358829 0.93 MEN1 (0.42) CYP2C19CYP3A4CYP2C9TMEM97SIGMAR1
SCHEMBL9358262 0.88 ACE (0.45) GAA
SCHEMBL9358267 0.88 ACE (0.45) GAA
SCHEMBL8681953 0.86 MEN1 (0.49) CYP2C19MEN1KMT2ANPSR1NPC1
SCHEMBL9354940 0.86 MEN1 (0.49) CYP2C19MEN1KMT2ANPSR1NPC1
SCHEMBL2440342 0.84 TMEM97 (0.57) CYP2C19TMEM97SIGMAR1MEN1KMT2A
SCHEMBL9358190 0.81 L3MBTL1 (0.47) CYP2C19MEN1KMT2ANPSR1NPC1
SCHEMBL9354656 0.81 TMEM97 (0.40) CYP2C19TMEM97SIGMAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0300189-B1 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-11-02 — — EP disclosed
US-5223489-A Treatment of ypertension and heart failure UJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-29 — — US disclosed
US-5142048-A Enzyme inhibitor; carbamoyl group-containing acids FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-08-25 — — US disclosed
US-4921855-A New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-05-01 — — US disclosed
EP-0300189-A2 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-25 — — EP disclosed
Send feedback